JOSEPH M. STEIN, M.D.; PHYLLIS J. BURDON, M.D.
With the well documented increase in the number of recognized cases of infection by Cryptococcus neoformans,7 renewed interest has been directed toward treatment. The discovery of amphotericin B5 initiated the use of a promising antifungal antibiotic in clinical practice. Some recent reports of its use in cases of cryptococcus infections of the central nervous system have engendered guarded optimism,2, 10, 1, 4, 8 but follow-up studies are still limited in time. The patient to be described was known to us for a total of nine years, and his cryptococcus infection was recognized and treated in its early stages for more
JOSEPH M. STEIN, PHYLLIS J. BURDON. CRYPTOCOCCUS NEOFORMANS INFECTION OF THE CENTRAL NERVOUS SYSTEM: A CASE TREATED BY AMPHOTERICIN B, WITH POSTMORTEM EXAMINATION(CRYPTOCOCCUS NEOFORMANS INFECTION OF THE CENTRAL NERVOUS SYSTEM: A CASE TREATED BY AMPHOTERICIN B, WITH POSTMORTEM EXAMINATION*). Ann Intern Med. 1960;52:445–453. doi: 10.7326/0003-4819-52-2-445
Download citation file:
Published: Ann Intern Med. 1960;52(2):445-453.
Infectious Disease, Neurology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use